UK grants mitochondrial license

After an appeal, an embryology regulator allows transfer of pronuclei into another woman's egg

Written byStephen Pincock
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

British scientists have welcomed a decision by the country's embryology watchdog last week (September 8) to permit a research group to try preventing the transmission of mitochondrial diseases, such as mitochondrial myopathies, from mother to child, using pronuclear transfer.

A team led by Doug Turnbull and Mary Herbert at the Newcastle Fertility Centre now have a green light to investigate the feasibility of moving pronuclei from the fertilized egg of a woman with mitochondrial disease to the egg of another woman, producing an embryo with the nuclear DNA of a man and a woman, and the mitochondrial DNA of another woman. The researchers will use donated fertilized eggs for the study and will not let any resulting embryos develop into a child.

Their initial application to the Human Fertilisation and Embryology Authority (HFEA) for permission to conduct the research was rejected in September 2004. "When the initial application came in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform